1-(5-isoquinolinesulfonyl)piperazine has been researched along with leukotriene b4 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jacobson, D; O'Flaherty, JT | 1 |
Bass, DA; Harvath, L; McCall, CE; McPhail, LC | 1 |
2 other study(ies) available for 1-(5-isoquinolinesulfonyl)piperazine and leukotriene b4
Article | Year |
---|---|
Protein kinase C blockers and neutrophil receptors for leukotriene B4.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Alkaloids; Humans; In Vitro Techniques; Isoquinolines; Kinetics; Leukotriene B4; Neutrophils; Piperazines; Platelet Activating Factor; Protein Kinase C; Receptors, Immunologic; Receptors, Leukotriene B4; Sphingosine; Staurosporine; Tetradecanoylphorbol Acetate; Thermodynamics | 1989 |
Inhibition of human neutrophil chemotaxis by the protein kinase inhibitor, 1-(5-isoquinolinesulfonyl) piperazine.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Cell Movement; Chemotaxis, Leukocyte; Complement C5; Complement C5a; Humans; Isoquinolines; Leukotriene B4; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Piperazines; Protein Kinase Inhibitors; Receptors, Formyl Peptide; Receptors, Immunologic | 1987 |